Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Pancreatic Neoplasms × Folfox protocol × Clear all

Status

Completed 5 Withdrawn 1 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5 Rectal Neoplasms 2 Colonic Neoplasms 2 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gallbladder Neoplasms 1 Disease Progression 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Bile Duct Neoplasms 1 Advanced Rectal Cancer 1 Adenocarcinoma of the Lower Rectum 1

Interventions

Gemcitabine 41 130-nm albumin-bound paclitaxel 25 Albumin-Bound Paclitaxel 18 Irinotecan 17 Oxaliplatin 15 Fluorouracil 15 pembrolizumab 13 Leucovorin 13 Taxes 11 Magnetic Resonance Spectroscopy 11 Nivolumab 10 Biopsy 8 Specimen Handling 7 Cisplatin 7 Carboplatin 6 irinotecan sucrosofate 5 folfirinox 5 durvalumab 5 Radiotherapy 5 dehydroftorafur 4 Paclitaxel 4 Ipilimumab 4 Cyclophosphamide 4 Capecitabine 4 defactinib 3 atezolizumab 3 Surveys and Questionnaires 3 Standard of Care 3 Practice Guidelines as Topic 3 Nutrition Assessment 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07243288 2025-11-21

RADIOPAN

Assistance Publique - Hôpitaux de Paris

Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡